The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the potential of endogenous cortisol and cortisone
metabolism as a biomarker for immunosuppressive agents disposition in Chinese renal
transplant recipients. If the blood concentrations of immunosuppressants can be predicted
successfully, this new probe may take place of current drug monitoring post transplantation.